Role in post-translational modification of M2-type pyruvate kinase in tumorigenesis and development

Ting Pan1, Jingwei Hao2, Yaoyao Wang2

  • 1College of Medical Technology, Qiqihar Medical University, Qiqihar Heilongjiang 161006. pan7160621@163.com.

Insights

Post-translational modifications regulate pyruvate kinase M2 (PKM2) protein kinase activity and cell localization, impacting tumor initiation and development. Understanding these modifications offers new cancer research avenues.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Pyruvate kinase M2 (PKM2) is crucial in glycolysis and frequently altered in tumors.
  • PKM2 exhibits both metabolic and non-metabolic functions, with its activity shifting between pyruvate kinase and protein kinase roles.
  • Post-translational modifications (PTMs) significantly influence PKM2's structure, localization, and activity.

Approach:

  • This review synthesizes recent findings on PKM2's diverse post-translational modifications.
  • Examines how specific PTMs, including phosphorylation, acetylation, glycosylation, ubiquitination, succinylation, and redox modifications, affect PKM2.
  • Focuses on the regulatory impact of these modifications on PKM2's cellular localization, structural transitions, and enzymatic activity.

Key Points:

  • Phosphorylation and acetylation drive PKM2 nuclear translocation, altering its cell localization.
  • Glycosylation and ubiquitination influence PKM2's structural transformation, favoring dimer formation.
  • Succinylation and redox modifications enhance PKM2's kinase activity by modulating its enzymatic function.

Conclusions:

  • PTMs critically regulate PKM2's dual functions and cellular behavior.
  • Altered PKM2 activity and localization due to PTMs play significant roles in tumor initiation and progression.
  • Targeting PKM2 PTMs presents a promising strategy for cancer therapy development.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
50.4K